Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 1, 2006, Pages 75-81

  Nielsen, Vance G ^a   Cohen, Benjamin M ^b   Cohen, Eli ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Haemoscope Corporation   (United States)

Author keywords

Aprotinin; Coagulation; Factor XIII; Fibrinolysis; Monitoring; Thrombelastography; Tissue plasminogen activator

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 13; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; FIBRINOLYSIS; HUMAN; KINETICS; LABORATORY; LYSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOELASTOGRAPHY; YOUNG MODULUS;

EID: 31644436226     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000198047.35010.77     Document Type: Article

References (20)

1. Kang Y, Borland LM, Picone J, Martin LK. Intraoperative coagulation changes in children undergoing liver transplantation. Anesthesiology 1989; 71:44-47.
2. Martin LK, Kang Y, De Wolf AM. Coagulation changes immediately following liver graft reperfusion. Transplant Proc 1991; 23:1946.
3. Himmelreich G, Muser M, Neuhaus P, Bechstein WO, Slama KJ, Jochum M, Riess H. Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation. Transplantation 1992; 53:132-136.
4. McNicol PL, Liu G, Harley ID, McCall PR, Przybylowski GM, Bowkett J, et al. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastography. Anaesth Intensive Care 1994; 22:659-665.
5. Kaspar M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg 1997; 85:281-285.
6. Viana JS, Pereira MG, Lozano L, Vieira H, Palmeiro A, Lourenco M, et al. Thrombelastographic evidence of hyperfibrinolysis during liver transplantation for familial amyloidotic polyneuropathy ATTR met 30. Transplant Proc 2000; 32:2645-2646.
7. Palmer JD, Francis DA, Roath OS, Francis JL, Iannotti F. Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin. J Neurol Neurosurg Psychiatry 1995; 58:104-106.
8. Yamakage M, Tsujiguchi N, Kohro S, Tsuchida H, Namiki A. The usefulness of celite-activated thromboelastography for evaluation of fibrinolysis. Can J Anaesth 1998; 45:993-996.
9. Liu G, Bowkett J, Przybylowski G, Bellomo R, McNicol PL. Postoperative fibrinolysis diagnosed by thrombelastography. Anaesth Intensive Care 2000; 28:77-81.
10. Cvachovec K, Horacek M, Vislocky I. A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome. Eur J Anaesthesiol 2000; 17:173-176.
11. Vorweg M, Hartmann B, Knuttgen D, Jahn MC, Doehn M. Management of fulminant fibrinolysis during abdominal aortic surgery. J Cardiothorac Vasc Anesth 2001; 15:764-767.
12. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002; 89:722-728.
13. De Souza RL, Short T, Warman GR, Maclennan N, Young Y. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography. Anaesth Intensive Care 2004; 32:580-587.
14. Barabas E, Szell E, Bajusz S. Screening for fibrinolysis inhibitory effect of synthetic thrombin inhibitors. Blood Coagul Fibrinolysis 1993; 4: 243-248.
15. Romisch J, Vermohlen S, Feussner A, Stohr H. The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 1999; 29:292-299.
16. Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, Stojanovich L. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis 2001; 12:627-637.
17. Nielsen VG, Crow JP, Zhou F, Parks DA. Peroxynitrite inactivates tissue plasminogen activator. Anesth Analg 2004; 98:1312-1317.
18. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90.
19. Nielsen VG, Lyerly RT, Gurley WQ. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004; 99:1587-1592.
20. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via Thrombelastography®: critical roles of fibrinogen and Factors II, VII, X and XII. Acta Anaesthesiol Scand 2005; 49:222-231.